Food science: Insight into emulsions
Neutron scattering techniques help characterise the structure of a particle based emulsifier
Showing 781 - 800 of 1168 results
Melbourne
Move over Curiosity Rover: New LEGO model of nuclear instrument
Executive Manager Consulting Services and Commercial Manager, Detection and Imaging
Dr Bruce Begg is Executive Manager Consulting Services and Commercial Manager, Detection and Imaging.
Roadmap for future development of sovereign infrastructure, capabilities and expertise
ANSTO has a new roadmap for future development of its sovereign infrastructure, capabilities and expertise.
Sydney
Sydney
Scientist awarded for work probing nanoscale magnetic structures in thin films using neutron scattering
Synchrotron light illuminates key structures in study on genetic basis for COVID-19 immunity
Today an international team has provided a molecular basis for strong immunity against COVID-19.
Services - Echidna
Sample environments, Data Analysis, Mail-in Services.
More progress understanding how COVID-19 invades the body
Using the Australian Synchrotron, an international team of researchers has characterised an important interaction that helps the SARS-CoV-2 virus invade human cells.
New study reveals understanding of a basic physical property of charged particles in microgravity
International study has revealed a clustering of charged particles in the microgravity environment of space,with implications for the development of materials and better drugs that depend on the mixing of two or more charged particles.
Nobel meeting
Young ANSTO biomedical materials scientist will attend Nobel Laureate meeting.
Inaugural particle therapy study tour to Japan
Australian researchers and clinicians have recently returned from Japan where they investigated the use of advanced radiation therapy for cancer using heavy ions at particle therapy facilities on a study tour .
Fine-tuning chemistry
Doping with transition metals produced stability in bismuth oxide.
Carbon ion therapy research
ANSTO research focuses on an advanced form of cancer treatment under consideration in Australia.
Meeting attracts large group of users
Combined users meeting highlights how ANSTO expertise and infrastructure can assist research community.
Potential true theranostic agent for cancer produced
Scandium 47, a therapeutic radioisotope and potential theranostic, has been produced for the first time at ANSTO. Theranostics are used to both diagnose and treat disease.
Personalised cancer therapy
Research collaboration with University of Sydney focuses on a personalised approach to cancer treatment.
Stable Isotope Analyst